Jacobi Capital Management LLC Buys 56 Shares of Danaher Co. (NYSE:DHR)

Jacobi Capital Management LLC grew its holdings in Danaher Co. (NYSE:DHR) by 0.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,166 shares of the conglomerate’s stock after acquiring an additional 56 shares during the period. Jacobi Capital Management LLC’s holdings in Danaher were worth $2,104,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also made changes to their positions in the company. Heck Capital Advisors LLC purchased a new position in shares of Danaher in the fourth quarter valued at about $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher in the fourth quarter valued at about $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher in the fourth quarter valued at about $31,000. Strategic Financial Concepts LLC purchased a new position in shares of Danaher in the fourth quarter valued at about $31,000. Finally, Pineridge Advisors LLC lifted its position in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Trading Up 1.0 %

DHR opened at $207.73 on Friday. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The stock has a market cap of $148.47 billion, a price-to-earnings ratio of 39.34, a P/E/G ratio of 2.66 and a beta of 0.83. The stock’s 50 day moving average price is $224.58 and its 200-day moving average price is $245.09. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the company earned $2.09 EPS. On average, equities analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.62%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is 24.24%.

Wall Street Analyst Weigh In

DHR has been the topic of several research analyst reports. Raymond James restated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. The Goldman Sachs Group set a $250.00 target price on Danaher in a research report on Wednesday, January 15th. Citigroup decreased their target price on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 30th. Scotiabank initiated coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $278.00.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.